Sh Pharmaceutical reported CNY2.77B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Jiangsu Hengrui CNY 2.56B 259.7M Mar/2026
Sh Fosun Pharma CNY 1.65B 88.09M Mar/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
WuXi AppTec CNY 7.98B 2.34B Jun/2026